Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
The firings are in addition to the roughly 75,000 workers who have taken a buyout that Trump and Musk have offered to get them to leave voluntarily, which equals about 3% of the 2.3-million-person ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today. Joseph Stringer has given his Hold rating due to a combination of factors surrounding ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
The first phase of the Champions League is over. Liverpool lost 3-2 away at PSV on Wednesday but remained top of the table after Barcelona could only draw with Atalanta. Arsenal ensured they ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
New from Leupold, the VX 6-HD Gen. 2 riflescopes takes an existing winning platform and adds to it internal and external upgrades that really make it stand out with hunters looking for the very best.
If you're in the market for a new scope, I recommend VX-6HD GEN 2 models over standard VX-6HD models. Hunters shouldn't swap every VX-HD scope they already have on their rifles for a GEN 2 unless ...
The new VX-6HD Gen 2 scopes feature all those standard Gold Ring features built around the precision adjustments that have made Mark 5HD Black Ring scopes successful in precision rifle competitions.
The VX One Australian Championship concluded today at the Royal Prince Alfred Yacht Club (RPAYC), and a new Australian Champion was crowned. The Beast AUS352, skippered by Jordan Barney, with siblings ...
Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. This therapy seems likely to become the new standard of care ... 1/2 study evaluating VX-522, a messenger RNA therapy ...